Predicting anti-cancer activity in flavonoids: a graph theoretic approach

Simon Mukwembi1, Farai Nyabadza2

  • 1School of Mathematics, University of The Witwatersrand, Johannesburg, South Africa.

Scientific Reports
|February 27, 2023
PubMed

Insights

This study introduces a new mathematical model using graph activity to predict the melanoma healing potential of plant-derived flavonoids. The model aids in identifying effective and safe drug candidates for melanoma treatment.

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Oncology

Background:

  • Drug development faces high failure rates due to efficacy and safety issues.
  • Melanoma treatment requires efficient identification of effective therapeutic compounds.
  • Flavonoids, natural plant compounds, show potential for anti-cancer activity.

Purpose of the Study:

  • To develop a mathematical model for predicting the anti-melanoma efficacy of flavonoids.
  • To introduce a novel graph parameter, 'graph activity,' to quantify healing properties.
  • To facilitate the screening and identification of potential flavonoid-based drug candidates for melanoma.

Main Methods:

  • Development of a novel mathematical model based on a new graph parameter called 'graph activity'.
  • Application of the model to predict the anti-melanoma properties of flavonoids.
  • Validation of the model using existing datasets and evaluation of its predictive accuracy.

Main Results:

  • The developed model demonstrates a high coefficient of determination, indicating accurate prediction of anti-cancer activities.
  • The 'graph activity' parameter effectively captures the melanoma healing properties of flavonoids.
  • The model successfully reproduces anti-cancer activities from known datasets.

Conclusions:

  • The novel mathematical model and 'graph activity' parameter offer a powerful tool for predicting flavonoid efficacy against melanoma.
  • This approach can significantly accelerate the screening and identification of promising flavonoid compounds for drug development.
  • The model aids in prioritizing compounds for further investigation, potentially reducing drug development costs and timelines.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
408
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K